Need professional-grade analysis? Visit stockanalysis.com
$761.61M
95.23
N/A
N/A
Price Chart
Risk-Adjusted Performance
ARS Pharmaceuticals, Inc (SPRY) Price Performance
ARS Pharmaceuticals, Inc (SPRY) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $7.54, down 7.71% from the previous close.
Over the past year, SPRY has traded between a low of $6.73 and a high of $18.35. The stock has lost 40.2% over this period. It is currently 58.9% below its 52-week high.
ARS Pharmaceuticals, Inc has a market capitalization of $761.61M, with a price-to-earnings ratio of 95.23.
About ARS Pharmaceuticals, Inc
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $84.28M
- EBITDA
- $-178,080,992
- Profit Margin
- -203.25%
- EPS (TTM)
- -1.74
- Book Value
- 1.15
Technical Indicators
- 52 Week High
- $18.90
- 52 Week Low
- $6.66
- 50 Day MA
- $9.92
- 200 Day MA
- $11.90
- Beta
- 0.78
Valuation
- Trailing P/E
- 95.23
- Forward P/E
- -10.75
- Price/Sales
- 9.04
- Price/Book
- 6.66
- Enterprise Value
- $685.14M